CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 349.00
+4.00 (1.16%)
Jul 16, 2026, 9:46 AM JST
CellSource Market Cap
CellSource has a market cap or net worth of 6.85 billion as of July 15, 2026. Its market cap has decreased by -50.56% in one year.
Market Cap
6.85B
Enterprise Value
2.06B
Revenue
3.67B
Ranking
n/a
PE Ratio
97.71
Stock Price
349.00
Market Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 6.85B, a decrease of -49.20%. That is a compound annual growth rate of -9.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 6.85B | -13.43% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| K Pharma,Inc. | 8.29B |
| StemCell Institute | 7.84B |
| OncoTherapy Science | 7.67B |
| Kidswell Bio | 7.49B |
| ADR Biomedical Holdings | 7.15B |
| MEDINET | 7.00B |
| Carna Biosciences | 6.96B |
| BrightPath Biotherapeutics | 6.94B |